Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
national blog main
national top stories
4
×
boston blog main
boston top stories
clinical trials
europe top stories
fda
national
new york top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
europe blog main
indiana blog main
indiana top stories
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alkermes
allergan
amy heimberer
arena pharmaceuticals
barrow neurological institute
ben and catherine ivy foundation
billy dunn
biogen
What
drug
4
×
medicine
4
×
fda
cancer
patients
weight
alkermes
alzheimer's
antipsychotic
approved
atrophy
bad
benefits
brain
case
caveats
commonly
daily
designed
disease
doses
effect
eisai
evrysdi
failed
favor
fight
flags
fortune
friday
gain
goes
green
help
higher
home
incidence
intended
lights
liquid
Language
unset
Current search:
medicine
×
biotech
×
" national top stories "
×
drug
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?